Stock INTI INHIBITOR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Inhibitor Therapeutics, Inc.

Equities

INTI

US45720M1053

Market Closed - OTC Markets
Other stock markets
 17:29:55 16/05/2024 BST 		5-day change 1st Jan Change
0.089 USD +0.03% Intraday chart for Inhibitor Therapeutics, Inc. -35.32% -3.26%
03-29 Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Introducing Inhibitor Therapeutics, Inc. Announces Scientific Advisory Board CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Introducing Inhibitor Therapeutics, Inc. New Scientific Advisory Board
AQ
Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins University
PR
INHIBITOR THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
INHIBITOR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
INHIBITOR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Changes in Control or Registrant, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
INHIBITOR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Inhibitor Therapeutics : NOTICE OF PENDENCY OF DERIVATIVE AND CLASS ACTIONS, PROPOSED SETTLEMENT AND SETTLEMENT HEARING - Form 8-K
PU
INHIBITOR THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
INHIBITOR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
INHIBITOR THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
INHIBITOR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
INHIBITOR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
INHIBITOR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
INHIBITOR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
INHIBITOR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
INHIBITOR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
INHIBITOR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
INHIBITOR THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
INHIBITOR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
INHIBITOR THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INTI Stock
  4. News Inhibitor Therapeutics, Inc.
  5. Press Releases